Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Calculus Capital (Funds)
Calculus Knowledge Intensive EIS Fund 3
29th Nov 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
107: Legal dos and don’ts of EIS and VCTs | Tom Wilde of Shoosmiths
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Advanced Oncotherapy
Life Sciences
Nearing the end-goal
By
Dr Martin Hall
08 Aug 2019
Primary Health Properties
Property
High security and accelerating dividend growth
By
Mike Foster
05 Aug 2019
Stay up-to-date with the latest research
Sign up to our newsletter
Shield Therapeutics Plc
Life Sciences
FDA approval opens door to major US opportunity
05 Aug 2019
Burford Capital
Financials
Results don’t need to be appealed
By
Dr Brian Moretta
05 Aug 2019
The Monthly: August 2019
01 Aug 2019
Gateley Plc
Services
Excellent full-year results
By
Steve Clapham
30 Jul 2019
Arbuthnot Banking Group Plc
Financials
1H’19 results: diversified, low-risk growth continues
By
Mark Thomas
29 Jul 2019
Utilities
UK Renewable Energy Infrastructure Funds
By
Nigel Hawkins
18 Jul 2019
City of London Investment Group
Financials
Finishing ahead in a volatile year for markets
By
Dr Brian Moretta
18 Jul 2019
Koovs Plc
Consumer
New year started with a bang
By
Jason Streets
18 Jul 2019
Redx Pharma
Life Sciences
Pan-RAF agreement strengthens balance sheet
18 Jul 2019
Prev
1
...
47
48
49
50
51
...
78
Next
